Company Profile
Business Type :
Main Markets :
Company area:
Year of Establishment :
Enterprise Certification:
Eachy Biopharmaceuticals was founded in 2013, focuses on prognostics innovation in the field of cardiovascular disease, inflammation, and metabolic syndrome. It provides the promising medical solution to clients using its proprietary technologies in biomarkers, human resource antibodies and high-throughput screening.
View MoreTrade Capacity
Commercial Terms | FOB,CFR,CIF | Nearest Port | SHANGHAI,, | Annual Output Value | US $2.5-$5 Million |
Terms of Payment | T/T,D/P,PayPai,WesternUnion,MoneyGram,D/A | Trade Staffs | 4~10 People | Export Percentage | 51% ~ 70% |
Export Year From | 2020 | Main Markets | NorthAmerica,SouthAmerica,EasternEurope,SoutheastAsia,Africa,Oceania,MidEast,EasternAsia,WesternEurope |
Leave A Message